On February 22, 2022, Stanley Meresman informed Guardant Health, Inc. (the Company) that he will not stand for re-election to the Company's Board of Directors (the Board) when his current term expires at the Company's next Annual Meeting of Stockholders, which will take place in June 2022. Mr. Meresman informed the Company that his decision was not a result of any dispute or disagreement with the Company, the Company's management or the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.88 USD | -0.59% |
|
-2.30% | +6.77% |
06-28 | Top Premarket Gainers | MT |
06-28 | Guggenheim Upgrades Guardant Health to Buy From Neutral, Price Target at $36 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.77% | 3.53B | |
-42.89% | 7.8B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
-26.12% | 533M | |
+1.19% | 297M | |
-26.05% | 142M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Announces That Stanley Meresman Will Not Stand for Re-Election to the Company’s Board of Directors